Hutch News

Hutch News

Stories tagged 'Cameron Turtle'

Fred Hutch at ASCO

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

June 5, 2018 | By Fred Hutch staff

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

View story >


3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant

$20M renewal of 4-decade-long federal grant to Hutch scientists

May 31, 2018 | By Susan Keown / Fred Hutch News Service

The National Cancer Institute has awarded Hutch with five years and nearly $20 million in funding for research to develop better therapies for people with blood cancers. The award is the latest renewal of a grant that has been funded continuously for more than 40 years.

View story >


Learning more from T-cell therapy trials

Fred Hutch Immunotherapy Integrated Research Center awards grants to Drs. Brian Till, Cameron Turtle

March 28, 2018 | By Susan Keown / Fred Hutch News Service

Two Hutch teams have received new funding for in-depth study of the results emerging from ongoing trials of genetically engineered T-cell therapies.

View story >


How new drugs become available to more patients

Filling in the unknowns on the balance between risk and benefit

Feb. 9, 2018 | by Susan Keown / Fred Hutch News Service

Often, new drugs are only approved to treat patients with advanced disease. But that can change as evidence accrues on the drugs’ risks and benefits.

View story >


10 highlights of Fred Hutch science in 2017

A look back at notable discoveries in cancer immunotherapy, HIV prevention and more

Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service

It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.

View story >


New insights into CAR T-cell therapy's potential side effects

Detailed study of cytokine release syndrome and neurologic toxicities could help make emerging cancer immunotherapies safer

Dec. 11, 2017 | By Fred Hutch staff

Detailed studies of two potential side effects of an emerging cancer immunotherapy could eventually help make this strategy, CAR T-cell therapy, safer for patients. The studies examined cytokine release syndrome and neurologic toxicities.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.